These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22897514)

  • 21. Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics.
    Tan H; Zhang H; Yang W; Fu Y; Gu Y; Du M; Cheng D; Shi H
    Nucl Med Commun; 2016 Aug; 37(8):792-9. PubMed ID: 27058361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of (99m)Tc-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with X-rays mammography, ultrasonography and magnetic resonance imaging.
    Ozülker T; Ozülker F; Ozpaçaci T; Bender O; Değirmenci H
    Hell J Nucl Med; 2010; 13(2):144-9. PubMed ID: 20808988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis.
    Sun Y; Wei W; Yang HW; Liu JL
    Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):450-63. PubMed ID: 23151912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validity of breast-specific gamma imaging for Breast Imaging Reporting and Data System 4 lesions on mammography and/or ultrasound.
    Cho MJ; Yang JH; Yu YB; Park KS; Chung HW; So Y; Choi N; Kim MY
    Ann Surg Treat Res; 2016 Apr; 90(4):194-200. PubMed ID: 27073789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world application of breast-specific gamma imaging, initial experience at a community breast center and its potential impact on clinical care.
    Zhou M; Johnson N; Blanchard D; Bryn S; Nelson J
    Am J Surg; 2008 May; 195(5):631-5; discussion 635. PubMed ID: 18374889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast-specific gamma imaging of invasive breast cancer: Clinicopathologic factors affecting detectability and correlation with mammographic findings.
    Park JY; Chun KA; Shin HJ; Yi SY; Kwon HJ; Park HJ
    Clin Imaging; 2018; 51():168-173. PubMed ID: 29857225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mammography and mammary ultrasonography: which examination sequence is preferable?].
    Müller-Schimpfle M; Stern W; Stoll P; Kaiser JW; Claussen CD
    Rofo; 1997 Oct; 167(4):348-54. PubMed ID: 9417262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual and semi-quantitative analyses of dual-phase breast-specific gamma imaging with Tc-99m-sestamibi in detecting primary breast cancer.
    Tan H; Jiang L; Gu Y; Xiu Y; Han L; Wu P; Zhang H; Shi H
    Ann Nucl Med; 2014 Jan; 28(1):17-24. PubMed ID: 24142630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast-specific gamma imaging in the detection of atypical ductal hyperplasia and lobular neoplasia.
    Ling CM; Coffey CM; Rapelyea JA; Torrente J; Teal CB; McSwain AP; Brem RF
    Acad Radiol; 2012 Jun; 19(6):661-6. PubMed ID: 22578225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient.
    Zhou M; Johnson N; Gruner S; Ecklund GW; Meunier P; Bryn S; Glissmeyer M; Steinbock K
    Am J Surg; 2009 Feb; 197(2):159-63. PubMed ID: 19185109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of Tc-99m-MIBI for breast carcinoma in correlation with mammography and sonography.
    Habib S; Maseeh-uz-Zaman ; Hameed A; Niaz K; Hashmi H; Kamal S
    J Coll Physicians Surg Pak; 2009 Oct; 19(10):622-6. PubMed ID: 19811712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography.
    Vural G; Atasever T; Ozdemir A; Oznur I; Karabacak NI; Gökçora N; Işik S; Unlü M
    Nuklearmedizin; 1997 Dec; 36(8):282-8. PubMed ID: 17068879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique.
    Weigert JM; Bertrand ML; Lanzkowsky L; Stern LH; Kieper DA
    AJR Am J Roentgenol; 2012 Jan; 198(1):W69-75. PubMed ID: 22194518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefit to Radiation Risk of Breast-specific Gamma Imaging Compared with Mammography in Screening Asymptomatic Women with Dense Breasts.
    Hendrick RE; Tredennick T
    Radiology; 2016 Nov; 281(2):583-588. PubMed ID: 27257949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging.
    Valente SA; Levine GM; Silverstein MJ; Rayhanabad JA; Weng-Grumley JG; Ji L; Holmes DR; Sposto R; Sener SF
    Ann Surg Oncol; 2012 Jun; 19(6):1825-30. PubMed ID: 22227922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of the results of 137 subclinical breast lesions excisions. Value of ultrasonography in the early diagnosis of breast cancer].
    Jacob D; Brombart JC; Muller C; Lefèbvre C; Massa F; Depoerck A
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):27-31. PubMed ID: 9091540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of feature analysis of breast-specific gamma imaging for predicting malignancy.
    Choi EK; Im JJ; Park CS; Chung YA; Kim K; Oh JK
    Eur Radiol; 2018 Dec; 28(12):5195-5202. PubMed ID: 29948076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients.
    Lee HS; Ko BS; Ahn SH; Son BH; Lee JW; Kim HJ; Yu JH; Kim SB; Jung KH; Ahn JH; Cha JH; Kim HH; Lee HJ; Song IH; Gong G; Park SH; Lee JJ; Moon DH
    Breast Cancer Res Treat; 2014 May; 145(1):91-100. PubMed ID: 24671359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement.
    Jaukovic LDj; Ajdinovic BZ; Jankovic ZD; Strbac M
    Nucl Med Rev Cent East Eur; 2006; 9(1):30-6. PubMed ID: 16791801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.